200 related articles for article (PubMed ID: 23121362)
1. Distinct and overlapping genomic profiles and antiviral effects of Interferon-λ and -α on HCV-infected and noninfected hepatoma cells.
Kohli A; Zhang X; Yang J; Russell RS; Donnelly RP; Sheikh F; Sherman A; Young H; Imamichi T; Lempicki RA; Masur H; Kottilil S
J Viral Hepat; 2012 Dec; 19(12):843-53. PubMed ID: 23121362
[TBL] [Abstract][Full Text] [Related]
2. Cellular Mechanism for Impaired Hepatitis C Virus Clearance by Interferon Associated with IFNL3 Gene Polymorphisms Relates to Intrahepatic Interferon-λ Expression.
Ferraris P; Chandra PK; Panigrahi R; Aboulnasr F; Chava S; Kurt R; Pawlotsky JM; Wilkens L; Osterlund P; Hartmann R; Balart LA; Wu T; Dash S
Am J Pathol; 2016 Apr; 186(4):938-51. PubMed ID: 26896692
[TBL] [Abstract][Full Text] [Related]
3. IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System.
Aboulnasr F; Hazari S; Nayak S; Chandra PK; Panigrahi R; Ferraris P; Chava S; Kurt R; Song K; Dash A; Balart LA; Garry RF; Wu T; Dash S
PLoS One; 2015; 10(12):e0141655. PubMed ID: 26657215
[TBL] [Abstract][Full Text] [Related]
4. Pegylated interferons Lambda-1a and alfa-2a display different gene induction and cytokine and chemokine release profiles in whole blood, human hepatocytes and peripheral blood mononuclear cells.
Freeman J; Baglino S; Friborg J; Kraft Z; Gray T; Hill M; McPhee F; Hillson J; Lopez-Talavera JC; Wind-Rotolo M
J Viral Hepat; 2014 Jun; 21(6):e1-9. PubMed ID: 24827902
[TBL] [Abstract][Full Text] [Related]
5. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.
Marcello T; Grakoui A; Barba-Spaeth G; Machlin ES; Kotenko SV; MacDonald MR; Rice CM
Gastroenterology; 2006 Dec; 131(6):1887-98. PubMed ID: 17087946
[TBL] [Abstract][Full Text] [Related]
6. Alcohol attenuates anti-HCV function of IFN-λ1 through up-regulation of PLASy expression in human hepatic cells.
Ran M; Huang J; Liang H; Jiang J; Liang B; Ning C; Zang N; Liao W; Liu H; Qin F; Yang Q; Ho W; Ye L; Chen H
J Med Virol; 2018 Jun; 90(6):1112-1120. PubMed ID: 29446489
[TBL] [Abstract][Full Text] [Related]
7. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
Liu B; Chen S; Guan Y; Chen L
PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
[TBL] [Abstract][Full Text] [Related]
8. Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus.
Jilg N; Lin W; Hong J; Schaefer EA; Wolski D; Meixong J; Goto K; Brisac C; Chusri P; Fusco DN; Chevaliez S; Luther J; Kumthip K; Urban TJ; Peng LF; Lauer GM; Chung RT
Hepatology; 2014 Apr; 59(4):1250-61. PubMed ID: 23913866
[TBL] [Abstract][Full Text] [Related]
9. Interferon-lambda (IFN-λ) induces signal transduction and gene expression in human hepatocytes, but not in lymphocytes or monocytes.
Dickensheets H; Sheikh F; Park O; Gao B; Donnelly RP
J Leukoc Biol; 2013 Mar; 93(3):377-85. PubMed ID: 23258595
[TBL] [Abstract][Full Text] [Related]
10. Persistence of HCV in quiescent hepatic cells under conditions of an interferon-induced antiviral response.
Bauhofer O; Ruggieri A; Schmid B; Schirmacher P; Bartenschlager R
Gastroenterology; 2012 Aug; 143(2):429-38.e8. PubMed ID: 22522091
[TBL] [Abstract][Full Text] [Related]
11. Antiviral potency analysis and functional comparison of consensus interferon, interferon-alpha2a and pegylated interferon-alpha2b against hepatitis C virus infection.
Erickson AK; Seiwert S; Gale M
Antivir Ther; 2008; 13(7):851-62. PubMed ID: 19043919
[TBL] [Abstract][Full Text] [Related]
12. Human type 2 myeloid dendritic cells produce interferon-λ and amplify interferon-α in response to hepatitis C virus infection.
Zhang S; Kodys K; Li K; Szabo G
Gastroenterology; 2013 Feb; 144(2):414-425.e7. PubMed ID: 23089201
[TBL] [Abstract][Full Text] [Related]
13. Combinations of lambda interferon with direct-acting antiviral agents are highly efficient in suppressing hepatitis C virus replication.
Friborg J; Levine S; Chen C; Sheaffer AK; Chaniewski S; Voss S; Lemm JA; McPhee F
Antimicrob Agents Chemother; 2013 Mar; 57(3):1312-22. PubMed ID: 23274666
[TBL] [Abstract][Full Text] [Related]
14. Impairment of type I but not type III IFN signaling by hepatitis C virus infection influences antiviral responses in primary human hepatocytes.
Friborg J; Ross-Macdonald P; Cao J; Willard R; Lin B; Eggers B; McPhee F
PLoS One; 2015; 10(3):e0121734. PubMed ID: 25826356
[TBL] [Abstract][Full Text] [Related]
15. Impaired antiviral activity of interferon alpha against hepatitis C virus 2a in Huh-7 cells with a defective Jak-Stat pathway.
Hazari S; Chandra PK; Poat B; Datta S; Garry RF; Foster TP; Kousoulas G; Wakita T; Dash S
Virol J; 2010 Feb; 7():36. PubMed ID: 20149251
[TBL] [Abstract][Full Text] [Related]
16. IL-28B (IFN-λ3) and IFN-α synergistically inhibit HCV replication.
Shindo H; Maekawa S; Komase K; Miura M; Kadokura M; Sueki R; Komatsu N; Shindo K; Amemiya F; Nakayama Y; Inoue T; Sakamoto M; Yamashita A; Moriishi K; Enomoto N
J Viral Hepat; 2013 Apr; 20(4):281-9. PubMed ID: 23490373
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic response.
Naggie S; Osinusi A; Katsounas A; Lempicki R; Herrmann E; Thompson AJ; Clark PJ; Patel K; Muir AJ; McHutchison JG; Schlaak JF; Trippler M; Shivakumar B; Masur H; Polis MA; Kottilil S
Hepatology; 2012 Aug; 56(2):444-54. PubMed ID: 22331604
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of IFN-λ genes in hepatitis C virus-infected hepatocytes via IRF-3·IRF-7·NF-κB complex.
Lee HC; Narayanan S; Park SJ; Seong SY; Hahn YS
J Biol Chem; 2014 Feb; 289(8):5310-9. PubMed ID: 24385435
[TBL] [Abstract][Full Text] [Related]
19. HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons.
Thomas E; Gonzalez VD; Li Q; Modi AA; Chen W; Noureddin M; Rotman Y; Liang TJ
Gastroenterology; 2012 Apr; 142(4):978-88. PubMed ID: 22248663
[TBL] [Abstract][Full Text] [Related]
20. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
